LATEST

Is your scribe raising your risk of a malpractice lawsuit?
ADT plus salvage RT lowers PCa metastases, raises survivalA recent review of two phase III randomized controlled trials demonstrated that addition of androgen deprivation therapy to salvage pelvic radiation therapy for prostate cancer recurrence after radical prostatectomy reduces the risk of metastases and improves overall survival.
2018 ICD-10-CM codes, guidelines: What you need to knowThis article provides an overview of the new 2018 ICD-10-CM codes, revisions, and deletions that are relevant to urology practice.
Prostate MRI has value, but results are not ‘gospel’Magnetic resonance imaging (MRI) of the prostate may be used in many clinical scenarios, including primary screening, active surveillance, and in patients with a previous negative biopsy and rising PSA. In this interview, Scott Eggener, MD, explains whether MRI is warranted in each of these situations and the benefits and challenges this technology presents.
How to bill for discontinued vasectomy procedure
Can urologists find gold in Advanced APMs?
How will urologists fare under 2018 MIPS rule?
Prostate MRI-Bx may ID partial gland ablation candidatesInformation from magnetic resonance imaging and systematic biopsy may be used to identify candidates for partial gland ablation among men with recurrent localized prostate cancer after radiation therapy, researchers from Memorial Sloan Kettering Cancer Center reported at the AUA annual meeting in Boston.
5-ARI use does not raise erectile dysfunction riskThe risk of erectile dysfunction is not increased with the use of a 5-alpha-reductase inhibitor compared with an alpha-blocker for the treatment of BPH.
Data cast light on ED/5-ARI connection

Poll

View Results